Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Aceclofenac 100 mg vs Airtal in Healthy Volunteers
NCT05339373Phase 1Completed
- Sponsor
- Pharmtechnology
- Start
- Apr 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aceclofenac in osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS) (2 arms), sponsored by Pharmtechnology. Primary endpoints: Maximum Plasma Concentration (Cmax) at 24 hours and Area Under the Plasma Concentration-Time Curve from Time Zero to Time t at 24 hours. Started Apr 2022; status: completed.
02
Drugs
aceclofenac
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT05339373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05339373.